Literature DB >> 22969945

The herbal medicine rikkunshito exhibits strong and differential adsorption properties for bile salts.

Yoshio Araki1, Ken-Ichi Mukaisho, Yoshihide Fujiyama, Takanori Hattori, Hiroyuki Sugihara.   

Abstract

Anti-secretory drugs, particularly proton pump inhibitors (PPIs), are the preferred treatment agents for patients with gastroesophageal reflux disease (GERD). However, refractory GERD, which may manifest as an incomplete or lack of response to PPI therapy, is common. Despite the administration of PPIs for symptomatic control, duodenogastroesophageal reflux (DGER) containing bile is successfully controlled in only one-third of patients. It has previously been reported that the traditional Japanese herbal medicine rikkunshito, which has a prokinetic action on gastric emptying, exhibits clinically therapeutic effects against GERD and DGER that does not respond to PPIs. However, the precise mechanisms responsible for the effects of rikkunshito are still unknown. It has been suggested that the cytotoxicity of the bile salts in the gut lumen is important in GERD and DGER. The aim of the present study was to investigate whether rikkunshito is able to adsorb bile salts through the mechanism by which it ameliorates the symptoms of GERD and DGER. The binding capacities of rikkunshito for bile salts were measured using Langmuir's method. The morphology of rikkunshito was also observed by light microscopy. Rikkunshito strongly adsorbed bile salts. The binding capabilities of rikkunshito were far beyond those of a typical dietary fiber, α-cellulose, or an oral adsorbent. In addition, rikkunshito had higher binding capacities for hydrophobic bile salts as compared with hydrophilic bile salts. In conclusion, rikkunshito has a great capacity to adsorb bile salts. This may be part of the mechanism(s) responsible for the therapeutic effects of rikkunshito in patients with GERD and DGER.

Entities:  

Year:  2012        PMID: 22969945      PMCID: PMC3438557          DOI: 10.3892/etm.2012.478

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  38 in total

1.  Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.

Authors:  John M Inadomi; Lisa McIntyre; Latoya Bernard; A Mark Fendrick
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

Review 2.  Japanese herbal medicine in functional gastrointestinal disorders.

Authors:  H Suzuki; J M Inadomi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2009-03-25       Impact factor: 3.598

3.  Changes in fecal composition and colonic function due to cereal fiber.

Authors:  J H Cummings; M J Hill; D J Jenkins; J R Pearson; H S Wiggins
Journal:  Am J Clin Nutr       Date:  1976-12       Impact factor: 7.045

4.  Germinated barley foodstuff exhibits different adsorption properties for hydrophilic versus hydrophobic bile acids.

Authors:  Y Araki; A Andoh; Y Fujiyama; O Kanauchi; K Takenaka; A Higuchi; T Bamba
Journal:  Digestion       Date:  2001       Impact factor: 3.216

5.  Alterations in intestinal microflora, faecal bile acids and short chain fatty acids in dextran sulphate sodium-induced experimental acute colitis in rats.

Authors:  Y Araki; A Andoh; T Tsujikawa; Y Fujiyama; T Bamba
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-02       Impact factor: 2.566

6.  Dietary bile acids inhibit potentially elemental diet-induced small intestinal atrophy in rats.

Authors:  Yoshio Araki; Akira Andoh; Akira Sasaki; Mitsue Shimada; Shigeki Bamba; Sanae Fujino; Yoshihide Fujiyama
Journal:  Int J Mol Med       Date:  2002-11       Impact factor: 4.101

7.  Therapeutic effects of an oral adsorbent on acute dextran sulphate sodium-induced colitis and its recovery phase in rats, especially effects of elimination of bile acids in gut lumen.

Authors:  Y Araki; T Tsujikawa; A Andoh; M Sasaki; Y Fujiyama; T Bamba
Journal:  Dig Liver Dis       Date:  2000-11       Impact factor: 4.088

8.  Hydrophilic and hydrophobic bile acids exhibit different cytotoxicities through cytolysis, interleukin-8 synthesis and apoptosis in the intestinal epithelial cell lines. IEC-6 and Caco-2 cells.

Authors:  Y Araki; Y Fujiyama; A Andoh; F Nakamura; M Shimada; H Takaya; T Bamba
Journal:  Scand J Gastroenterol       Date:  2001-05       Impact factor: 2.423

9.  Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring.

Authors:  Fabio Pace; Ornella Sangaletti; Stefano Pallotta; Paola Molteni; Gabriele Bianchi Porro
Journal:  Scand J Gastroenterol       Date:  2007-09       Impact factor: 2.423

10.  Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

Authors:  Takakazu Oka; Yoko Tamagawa; Sota Hayashida; Yuko Kaneda; Naoki Kodama; Sadatoshi Tsuji
Journal:  Biopsychosoc Med       Date:  2007-11-15
View more
  8 in total

1.  A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.

Authors:  Kazunari Tominaga; Mototsugu Kato; Hiroshi Takeda; Yasuyuki Shimoyama; Eiji Umegaki; Ryuichi Iwakiri; Kenji Furuta; Koichi Sakurai; Takeo Odaka; Hiroaki Kusunoki; Akihito Nagahara; Katsuhiko Iwakiri; Takahisa Furuta; Kazunari Murakami; Hiroto Miwa; Yoshikazu Kinoshita; Ken Haruma; Shin'ichi Takahashi; Sumio Watanabe; Kazuhide Higuchi; Motoyasu Kusano; Kazuma Fujimoto; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2014-02-18       Impact factor: 7.527

2.  Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  Front Pharmacol       Date:  2015-01-30       Impact factor: 5.810

Review 3.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

4.  Current pharmacological management of gastroesophageal reflux disease.

Authors:  Yao-Kuang Wang; Wen-Hung Hsu; Sophie S W Wang; Chien-Yu Lu; Fu-Chen Kuo; Yu-Chung Su; Sheau-Fang Yang; Chiao-Yun Chen; Deng-Chyang Wu; Chao-Hung Kuo
Journal:  Gastroenterol Res Pract       Date:  2013-06-26       Impact factor: 2.260

Review 5.  Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: a systematic review.

Authors:  Sachiko Mogami; Tomohisa Hattori
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-20       Impact factor: 2.629

6.  Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito.

Authors:  Yasuhisa Sakata; Kazunari Tominaga; Mototsugu Kato; Hiroshi Takeda; Yasuyuki Shimoyama; Toshihisa Takeuchi; Ryuichi Iwakiri; Kenji Furuta; Kouichi Sakurai; Takeo Odaka; Hiroaki Kusunoki; Akihito Nagahara; Katsuhiko Iwakiri; Takahisa Furuta; Kazunari Murakami; Hiroto Miwa; Yoshikazu Kinoshita; Ken Haruma; Shin'ichi Takahashi; Sumio Watanabe; Kazuhide Higuchi; Kazuma Fujimoto; Motoyasu Kusano; Tetsuo Arakawa
Journal:  BMC Gastroenterol       Date:  2014-07-02       Impact factor: 3.067

7.  Enhancement of catecholamine release from PC12 cells by the traditional Japanese medicine, rikkunshito.

Authors:  Yuko Nagamura; Kiyoshi Terawaki; Yasuhito Uezono; Toshihiko Tsukada
Journal:  BMC Complement Altern Med       Date:  2014-07-19       Impact factor: 3.659

Review 8.  Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions.

Authors:  Joseph Mermelstein; Alanna Chait Mermelstein; Maxwell M Chait
Journal:  Clin Exp Gastroenterol       Date:  2018-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.